Search results for "follow-up studies"

showing 10 items of 2210 documents

Persistent tachypnea of infancy: Follow up at school age

2020

Background Persistent tachypnea of infancy (PTI) is a rare pediatric lung disease of unknown origin. The diagnosis can be made by clinical presentation and chest high resolution computed tomography after exclusion of other causes. Clinical courses beyond infancy have rarely been assessed. Methods Patients included in the Kids Lung Register diagnosed with PTI as infants and now older than 5 years were identified. Initial presentation, extrapulmonary comorbidities, spirometry and clinical outcome were analyzed. Results Thirty-five children older than 5 years with PTI diagnosed as infants were analyzed. At the age of 5 years, 74% of the patients were reported as asymptomatic and did not develo…

Pulmonary and Respiratory MedicineSpirometryMaleHigh-resolution computed tomographyPediatricsmedicine.medical_specialtyRespiratory rateTachypneaAsymptomaticPulmonary function testing03 medical and health sciences0302 clinical medicine030225 pediatricsmedicineHumansChildTachypneaLungmedicine.diagnostic_testbusiness.industryInfantRespiratory Function Testsmedicine.anatomical_structure030228 respiratory systemChild PreschoolPediatrics Perinatology and Child HealthFemalePresentation (obstetrics)medicine.symptombusinessFollow-Up Studies
researchProduct

Late consequences of traumatic rupture of the diaphragm.

2013

A 54-year-old man was admitted to our clinic due to elevated γ-glutamyltransferase, without any clinical symptoms. About 25 years ago, he had undergone blunt abdominal and thoracic trauma during an accident. No diagnostic measures or therapy had been performed at that time. Serum bilirubin was normal, but the values for alanine transaminase, aspartate transaminase, and alkaline phosphatase were slightly above the reference range. Sonography of the abdomen revealed dilated intrahepatic bile ducts up to 3 mm in diameter and steatosis of the liver grade I. CT scan and MRI of the thorax and abdomen showed a giant hiatal hernia with transposition of upper abdominal organs into the chest. As the …

Pulmonary and Respiratory MedicineSpirometryThoraxMalemedicine.medical_specialtyDiaphragmAspartate transaminaseAbdominal InjuriesWounds NonpenetratingAsymptomaticHiatal herniaDiagnosis DifferentialMedicineHumansRupturebiologymedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseMagnetic Resonance ImagingSurgerymedicine.anatomical_structureAlanine transaminaseVocal foldsbiology.proteinAbdomenSurgeryRadiologymedicine.symptomCardiology and Cardiovascular MedicinebusinessTomography X-Ray ComputedFollow-Up StudiesThe Thoracic and cardiovascular surgeon
researchProduct

Bronchial to subclavian shunt in a CF patient. A potential pitfall for embolization

2003

Bronchial artery embolization is a well accepted and widely used technique in the management of massive haemoptysis in cystic fibrosis (CF). It can be a complex procedure requiring a deep knowledge of the bronchial artery anatomy including the possible bronchial anastomoses. We report a case of complex vascular anatomy of the left bronchial artery with multiple anastomoses with the ipsilateral subclavian artery as cause of non-attempted embolization. © 2003 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Pulmonary and Respiratory Medicinemedicine.medical_specialtyHemoptysisAdolescentCystic FibrosisVascular anatomymedicine.medical_treatmentSubclavian ArteryBronchial ArteriesAnastomosisCystic fibrosisRisk AssessmentCatheterizationEmbolizationArterio-Arterial Fistulamedicine.arterymedicineLeft bronchial arteryHumansEmbolizationTreatment FailurePediatrics Perinatology and Child HealthSubclavian arteryBronchial arterybusiness.industryrespiratory systemmedicine.diseaseEmbolization Therapeuticrespiratory tract diseasesSurgeryShunt (medical)RadiographyPediatrics Perinatology and Child HealthFemaleRadiologyBronchial arterybusinessFollow-Up StudiesJournal of Cystic Fibrosis
researchProduct

Quality of life improved following in-patient substance use disorder treatment

2015

Background Quality of life (QoL) is increasingly recognized as central to the broad construct of recovery in patients with substance use disorders (SUD). However, few longitudinal studies have evaluated changes in QoL after SUD treatment and included patients with SUD that were compulsorily hospitalized. This study aimed to describe QoL among in-patients admitted either voluntarily or compulsorily to hospitalization and to examine patterns and predictors of QoL at admission and at 6 months post treatment. Methods This prospective study followed 202 hospitalized patients with SUD that were admitted voluntarily (N=137) or compulsorily (N=65). A generic QoL questionnaire (QoL-5) was used to as…

Quality of lifeAdultMaleSubstance-Related DisordersResearchHealth StatusPublic Health Environmental and Occupational HealthSubstance use disorder treatmentTreatment outcomesCompulsory hospitalizationMiddle AgedhumanitiesSex FactorsTreatment OutcomeSurveys and QuestionnairesHumansFemaleLongitudinal StudiesProspective StudiesFollow-Up StudiesHealth and Quality of Life Outcomes
researchProduct

The Lasting Influences of Early Food-Related Variety Experience: A Longitudinal Study of Vegetable Acceptance from 5 Months to 6 Years in Two Populat…

2016

International audience; Children's vegetable consumption falls below current recommendations, highlighting the need to identify strategies that can successfully promote better acceptance of vegetables. Recently, experimental studies have reported promising interventions that increase acceptance of vegetables. The first, offering infants a high variety of vegetables at weaning, increased acceptance of new foods, including vegetables. The second, offering an initially disliked vegetable at 8 subsequent meals markedly increased acceptance for that vegetable. So far, these effects have been shown to persist for at least several weeks. We now present follow-up data at 15 months, 3 and 6 years ob…

QuestionnairesMale0301 basic medicineLongitudinal studyPhysiologyMaternal Health[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionEmotionsschool-aged childrenPsychological interventionBreastfeedinglcsh:MedicinePediatricsFamiliesEatingVegetablesMedicine and Health SciencesMedicineLongitudinal Studieslcsh:ScienceChildenfantChildrenBreast Milkpreferences2. Zero hungerMultidisciplinaryinfantsFollow up studiesAgriculture[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologiePlantsBody FluidsBreast FeedingMilkResearch Designrepeated exposureChild PreschoolAlimentation et NutritionFemaleAnatomyResearch ArticleAdultlifeAdolescentCropsContext (language use)WeaningResearch and Analysis MethodsFood Preferences03 medical and health sciencespreschool-childrenincreaseEnvironmental healthFood and NutritionENFANTS;LEGUMES;ACCEPTATION;APPRECIATION;CONSOMMATION;ALLAITEMENT;VARIETEHumansWeaningpatternschildhoodanalyse sensorielleSurvey Research030109 nutrition & dieteticsbusiness.industrylcsh:ROrganismsBiology and Life SciencesInfantlégumeBiotechnologyAge GroupsPeople and PlacesWomen's Healthlcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiePopulation GroupingsNeonatologyflavor-flavorPhysiological Processesbusiness[SDV.AEN]Life Sciences [q-bio]/Food and NutritionBreast feedingCrop ScienceFollow-Up Studies
researchProduct

Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study…

2020

BACKGROUND: Lynch syndrome is associated with an increased risk of colorectal cancer and with a broader spectrum of cancers, especially endometrial cancer. In 2011, our group reported long-term cancer outcomes (mean follow-up 55·7 months [SD 31·4]) for participants with Lynch syndrome enrolled into a randomised trial of daily aspirin versus placebo. This report completes the planned 10-year follow-up to allow a longer-term assessment of the effect of taking regular aspirin in this high-risk population.METHODS: In the double-blind, randomised CAPP2 trial, 861 patients from 43 international centres worldwide (707 [82%] from Europe, 112 [13%] from Australasia, 38 [4%] from Africa, and four [&l…

RESISTANT STARCHPlacebo-controlled study030204 cardiovascular system & hematology0302 clinical medicineLife Tables030212 general & internal medicine11 Medical and Health Sciencesmedia_commonRISKAspirineducation.field_of_studyAnti-Inflammatory Agents Non-SteroidalLOW-DOSE ASPIRINGeneral MedicineLynch syndrome3. Good healthIntention to Treat AnalysisAnti-Inflammatory Agents Non-Steroidal/adverse effectsmedicine.drugCHEMOPREVENTIONmedicine.medical_specialtyHeterozygote3122 CancersPopulationNEOPLASIAAspirin/adverse effectsPlaceboCAPP2 InvestigatorsMedication Adherence03 medical and health sciencesDouble-Blind MethodInternal medicineGeneral & Internal MedicineColorectal Neoplasms Hereditary Nonpolyposis/geneticsBENEFITSmedicinemedia_common.cataloged_instanceHumansEuropean unioneducationProportional Hazards ModelsIntention-to-treat analysisCancer preventionAspirinbusiness.industryMORTALITY3126 Surgery anesthesiology intensive care radiologymedicine.diseaseColorectal Neoplasms Hereditary NonpolyposisbusinessFollow-Up Studies
researchProduct

Exceptional Heterogeneity in Viral Evolutionary Dynamics Characterises Chronic Hepatitis C Virus Infection.

2016

The treatment of HCV infection has seen significant progress, particularly since the approval of new direct-acting antiviral drugs. However these clinical achievements have been made despite an incomplete understanding of HCV replication and within-host evolution, especially compared with HIV-1. Here, we undertake a comprehensive analysis of HCV within-host evolution during chronic infection by investigating over 4000 viral sequences sampled longitudinally from 15 HCV-infected patients. We compare our HCV results to those from a well-studied HIV-1 cohort, revealing key differences in the evolutionary behaviour of these two chronic-infecting pathogens. Notably, we find an exceptional level o…

RNA viruses0301 basic medicineMaleHepacivirusHIV InfectionsHepacivirusPathology and Laboratory Medicinemedicine.disease_causeVirus ReplicationHepatitis0302 clinical medicineImmunodeficiency VirusesMedicine and Health Sciences2.2 Factors relating to the physical environmentChronicAetiologylcsh:QH301-705.5Data Managementeducation.field_of_studybiologyHepatitis C virusLiver Diseasevirus diseasesHepatitis C3. Good healthPhylogeneticsInfectious DiseasesMedical MicrobiologyViral PathogensViral evolutionVirusesEvolutionary RateHIV/AIDS030211 gastroenterology & hepatologyFemalePathogensInfectionResearch Articlelcsh:Immunologic diseases. AllergyComputer and Information SciencesEvolutionary ProcessesEvolutionHepatitis C virusPopulationChronic Liver Disease and CirrhosisImmunologyMicrobiologyViral EvolutionVirusEvolution Molecular03 medical and health sciencesHepatitis - CVirologyRetrovirusesGeneticsmedicineHumansEvolutionary SystematicsEvolutionary dynamicseducationMicrobial PathogensMolecular BiologyTaxonomyEvolutionary BiologyFlavivirusesPopulation BiologyLentivirusOrganismsBiology and Life SciencesHIVMolecularHepatitis C Chronicbiology.organism_classificationVirologyHepatitis virusesOrganismal EvolutionViral ReplicationChronic infection030104 developmental biologyEmerging Infectious Diseaseslcsh:Biology (General)Viral replicationMicrobial EvolutionImmunologyHIV-1Parasitologylcsh:RC581-607Digestive DiseasesPopulation GeneticsFollow-Up Studies
researchProduct

A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system

2018

Background This study presents a novel methodology for estimating all-age, population-based incidence rates of norovirus and other pathogens that contribute to acute gastroenteritis in the United States using an integrated healthcare delivery system as a surveillance platform. Methods All cases of medically attended acute gastroenteritis within the delivery system were identified from April 1, 2014 through September 30, 2016. A sample of these eligible patients were selected to participate in two phone-based surveys and to self-collect a stool sample for laboratory testing. To ascertain household transmission patterns, information on household members with acute gastroenteritis was gathered…

RNA virusesMale0301 basic medicineTime FactorsEpidemiologyEthnic grouplcsh:MedicineSurveysPathology and Laboratory Medicinemedicine.disease_causeGeographical locationsOregonFeces0302 clinical medicineEpidemiologyMedicine and Health SciencesSampling (medicine)030212 general & internal medicineChildlcsh:Scienceeducation.field_of_studyMultidisciplinaryDelivery of Health Care IntegratedMiddle AgedTelephonesGastroenteritisDiarrheaInfectious DiseasesResearch DesignMedical MicrobiologyViral PathogensChild PreschoolVirusesEpidemiological MonitoringEngineering and TechnologyFemalePathogensEpidemiological Monitoringmedicine.symptomResearch ArticleDiarrheaAdultmedicine.medical_specialtyInfectious Disease ControlAdolescent030106 microbiologyPopulationEquipmentSample (statistics)Gastroenterology and HepatologyDisease SurveillanceResearch and Analysis MethodsMicrobiologyCalicivirusesYoung Adult03 medical and health sciencesSigns and SymptomsDiagnostic MedicinemedicineHumanseducationMicrobial PathogensAgedCommunication EquipmentSurvey Researchbusiness.industryNoroviruslcsh:ROrganismsBiology and Life SciencesUnited StatesInfectious Disease SurveillanceFamily medicineNorth AmericaNorovirusFeasibility Studieslcsh:QPeople and placesbusinessFollow-Up StudiesPLOS ONE
researchProduct

Radium-223 treatment in castration resistant bone metastatic prostate cancer. Should be the primary tumor always treated?

2019

Introduction: Radium-223 (223Ra) improves symptoms and survival in patients with bone metastatic castration-resistant prostate cancer (mCRPC). Study aim: To evaluate the impact of a previous radical prostatectomy (RP) on the outcome of 223Ra therapy in mCRPC patients. The primary prostate tumor left untreated could progress during 223Ra treatment. Materials and methods: mCRPC symptomatic patients treated with 223Ra were enrolled. Luteinizing Hormone-Releasing Hormone analogue was maintained. No other anticancer therapy was given. 223Ra was administered i.v. at the dose of 55 kBq/kg every 4 weeks for 6 cycles. Patients were stratified according to previous RP or not. Hematological toxicity w…

Radium-223Malemedicine.medical_specialtyUrologymedicine.medical_treatment030232 urology & nephrologyUrologyAntineoplastic AgentsBone NeoplasmsSettore MED/24 - UrologiaPrimary tumor03 medical and health sciencesProstate cancer0302 clinical medicineProstateRadium-222medicineHumansAgedProstatectomyRadiotherapybusiness.industryProstatectomyProstateChemoradiotherapy Adjuvantmedicine.diseasePrognosisRadical prostatectomyPrimary tumorSurvival AnalysisRadiation therapyProstatic Neoplasms Castration-Resistantmedicine.anatomical_structureTreatment OutcomeOncology030220 oncology & carcinogenesisConcomitantDisease ProgressionCastration resistant prostate cancerNeoplasm GradingRadiopharmaceuticalsbusinessmedicine.drugHormoneFollow-Up StudiesRadiumUrologic oncology
researchProduct

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal

2011

OBJECTIVE To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. RESEARCH DESIGN AND METHODS The 3,366 DREAM subjects at trial end who had not developed diabetes while taking double-blind study medication were transferred to single-blind placebo for 2 to 3 months before undergoing an oral glucose tolerance test. Glycemic status was analyzed for the trial plus washout period and for the washout period alone. RESULTS Following median (interquartile range) 71 (63–86) days drug withdrawal, overall glycemic status remained modestly improved in t…

RamiprilAdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism030209 endocrinology & metabolism030204 cardiovascular system & hematologyPlaceboRosiglitazone03 medical and health sciencesDrug withdrawal0302 clinical medicineRamiprilInterquartile rangeInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsGlycemicOriginal ResearchAdvanced and Specialized Nursingbusiness.industryIncidence (epidemiology)IncidenceClinical Care/Education/Nutrition/Psychosocial ResearchMiddle Agedmedicine.disease3. Good healthSurgerySubstance Withdrawal SyndromeTreatment OutcomeDiabetes Mellitus Type 2FemaleThiazolidinedionesRosiglitazonebusinessmedicine.drugFollow-Up StudiesDiabetes Care
researchProduct